EUVIMEDEUVIMED entdecken
Crossref

CHD2 ‐related epilepsy with eyelid myoclonia: Report of three cases

Hannah Padilla, Filippo Pinto E Vairo, Elaine C Wirrell iD, Lily C Wong-Kisiel, Anthony L Fine iD, Brendan C Lanpher, Kelsey M Smith iD

Epileptic Disorders · 2025

DOI: 10.1002/epd2.20305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epileptic Disorders, 2025. Verfasst von Hannah Padilla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic School of Medicine, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Epilepsies, Myoclonic, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to report three cases of epilepsy with eyelid myoclonia (EEM) with CHD2 pathogenic variants. A database of 134 patients with EEM evaluated at Mayo Clinic sites was searched to identify patients with CHD2 variants. The medical records of those identified were reviewed to describe their presentation, treatment, and clinical course. Three patients (2 males, 1 female) with EEM were found to harbor de novo CHD2 pathogenic variants (c.2636C>T p.(Ala879Val), c.3734delA p. (Lys1245Asnfs*4), and c.3896delTinsCG p. (Val1299Alafs*5)). All three patients had comorbid autism spectrum disorder (ASD), intellectual disability (ID), and attention deficit disorder (ADHD). Eyelid myoclonia was a prominent seizure type that persisted in the three patients despite trials of multiple antiseizure medications. Generalized tonic–clonic seizures occurred in two of the patients but were controlled with antiseizure medications. Genetic testing should be considered in patients presenting with EEM, especially when ADHD, ID, ASD, and drug‐resistant seizures are present. Further understanding of the relationship between CHD2 variants and epileptogenesis may provide important insights into the pathogenesis of EEM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsEpilepsies, MyoclonicEpilepsyFemaleHumansMaleAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderIntellectual Disability

Stichwörter der Autor:innen

CHD2epilepsyeyelid myocloniapathogenic variants

Substanzen

CHD2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
  • Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurology, Division of Epilepsy, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Elaine C Wirrell, Anthony L Fine, Kelsey M Smith

Zitieren

APA

Padilla, H., Pinto E Vairo, F., Wirrell, E. C., Wong-Kisiel, L. C., Fine, A. L., Lanpher, B. C., & Smith, K. M. (2025). CHD2 ‐related epilepsy with eyelid myoclonia: Report of three cases. Epileptic Disorders. https://doi.org/10.1002/epd2.20305

Vancouver

Padilla H, Pinto E Vairo F, Wirrell EC, Wong-Kisiel LC, Fine AL, Lanpher BC, et al. CHD2 ‐related epilepsy with eyelid myoclonia: Report of three cases. Epileptic Disorders. 2025. doi:10.1002/epd2.20305

BibTeX
@article{Padilla2025,
  author = {Padilla, Hannah and Pinto E Vairo, Filippo and Wirrell, Elaine C and Wong-Kisiel, Lily C and Fine, Anthony L and Lanpher, Brendan C and Smith, Kelsey M},
  title = {CHD2 ‐related epilepsy with eyelid myoclonia: Report of three cases},
  journal = {Epileptic Disorders},
  year = {2025},
  doi = {10.1002/epd2.20305}
}
Kostenlos starten →